These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36 related articles for article (PubMed ID: 17138674)
1. Is Higher Dose of Inhaled Treprostinil Truly Superior to Lower Dose of Inhaled Treprostinil in Patients With Pulmonary Hypertension Associated With Interstitial Lung Diseases? Genecand L; Lador F; Montani D; Perneger T Chest; 2024 May; 165(5):e161. PubMed ID: 38724160 [No Abstract] [Full Text] [Related]
2. Commentary: Is the glass half full or half empty? Halas M; Coselli JS J Thorac Cardiovasc Surg; 2023 Mar; 165(3):954-955. PubMed ID: 34511242 [No Abstract] [Full Text] [Related]
3. Digital health: Is the glass half-full or half-empty? Lampariello R; Labrique AB Health Policy Technol; 2020 Sep; 9(3):266-267. PubMed ID: 32837886 [No Abstract] [Full Text] [Related]
4. Assessment of daily life physical activities in pulmonary arterial hypertension. Mainguy V; Provencher S; Maltais F; Malenfant S; Saey D PLoS One; 2011; 6(11):e27993. PubMed ID: 22110770 [TBL] [Abstract][Full Text] [Related]
5. Transition from intravenous epoprostenol to intravenous treprostinil in pulmonary hypertension. Gomberg-Maitland M; Tapson VF; Benza RL; McLaughlin VV; Krichman A; Widlitz AC; Barst RJ Am J Respir Crit Care Med; 2005 Dec; 172(12):1586-9. PubMed ID: 16151039 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension. Lang I; Gomez-Sanchez M; Kneussl M; Naeije R; Escribano P; Skoro-Sajer N; Vachiery JL Chest; 2006 Jun; 129(6):1636-43. PubMed ID: 16778286 [TBL] [Abstract][Full Text] [Related]